HJGA
NVO

Hardman Johnston Global Advisors’s Novo Nordisk NVO Stock Holding History

Hardman Johnston Global Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-149,855
Closed -$10.3M – 76
2025
Q2 		$10.3M Buy
149,855
+37,199
+33% +$2.53M 0.46% 40
2025
Q1 		$7.82M Sell
112,656
-22,304
-17% -$1.84M 0.37% 46
2024
Q4 		$11.6M Sell
134,960
-9,238
-6% -$999K 0.48% 44
2024
Q3 		$17.2M Sell
144,198
-4,580
-3% -$611K 0.67% 36
2024
Q2 		$21.2M Sell
148,778
-19,388
-12% -$2.57M 0.82% 32
2024
Q1 		$21.6M Buy
168,166
+61,620
+58% +$7.34M 0.74% 38
2023
Q4 		$11M Buy
106,546
+66,330
+165% +$6.56M 0.35% 48
2023
Q3 		$3.66M Sell
40,216
-1,730
-4% -$152K 0.12% 55
2023
Q2 		$3.39M Sell
41,946
-17,750
-30% -$1.45M 0.11% 57
2023
Q1 		$4.75M Hold
59,696
– – 0.16% 55
2022
Q4 		$4.04M Hold
59,696
– – 0.16% 57
2022
Q3 		$2.97M Sell
59,696
-18,320
-23% -$981K 0.13% 54
2022
Q2 		$4.35M Buy
78,016
+5,320
+7% +$295K 0.18% 53
2022
Q1 		$4.04M Hold
72,696
– – 0.13% 54
2021
Q4 		$4.07M Buy
72,696
+336
+0.5% +$18.2K 0.11% 52
2021
Q3 		$3.47M Buy
72,360
+1,300
+2% +$62.8K 0.09% 52
2021
Q2 		$2.98M Hold
71,060
– – 0.07% 53
2021
Q1 		$2.4M Buy
71,060
+30,500
+75% +$1.09M 0.07% 53
2020
Q4 		$1.42M Hold
40,560
– – 0.04% 58
2020
Q3 		$1.41M Sell
40,560
-36,420
-47% -$1.21M 0.05% 57
2020
Q2 		$2.52M Buy
+76,980
New +$2.46M 0.11% 54
2016
Q4 		– Sell
-465,576
Closed -$9.68M – 79
2016
Q3 		$9.68M Buy
465,576
+7,820
+2% +$194K 0.44% 46
2016
Q2 		$12.3M Sell
457,756
-27,234
-6% -$747K 0.63% 45
2016
Q1 		$13.1M Buy
+484,990
New +$13M 0.77% 42

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hardman Johnston Global Advisors's NVO Position: Q3 2025 in Review

Hardman Johnston Global Advisors sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 149,855 shares — an estimated $10.3M sold.

Hardman Johnston Global Advisors first reported a position in NVO in Q1 2016 and held it in 24 quarters. The position peaked at $21.6M in Q1 2024. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Hardman Johnston Global Advisors reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Hardman Johnston Global Advisors sold 149,855 Novo Nordisk shares in Q3 2025, an estimated $10.3M.
  • Hardman Johnston Global Advisors first reported a position in Novo Nordisk in Q1 2016 and held it in 24 quarters.
  • Hardman Johnston Global Advisors's Novo Nordisk position peaked at $21.6M in Q1 2024.
  • 1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Hardman Johnston Global Advisors's 13F filing for Q3 2025, filed 27 Oct 2025.